Frontier Capital Management CO LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Frontier Capital Management CO LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 19, 2021	SELL	$65.07 - $98.24 $13 Million - $19.6 Million	-199,534 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $1.86 Million - $2.45 Million	31,488 Added 18.74%	199,534 $13 Million
Q2 2020 Jul 17, 2020	SELL	$29.01 - $74.23 $880,946 - $2.25 Million	-30,367 Reduced 15.3%	168,046 $12.3 Million
Q1 2020 Apr 16, 2020	BUY	$27.51 - $57.29 $57,715 - $120,194	2,098 Added 1.07%	198,413 $6.75 Million
Q4 2019 Feb 14, 2020	BUY	$40.86 - $57.65 $4.37 Million - $6.17 Million	107,033 Added 119.88%	196,315 $10.7 Million

Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $3.34 Million - $4.42 Million	89,282 New	89,282 $3.73 Million

565K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.49B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Capital Management CO LLC with notifications on news.